ARandomized, Double-Blind, Placebo-Controlled, Parallel Group Study of Vardenafil 10 mg Twice Daily to Assess the Effect on Urodynamics in Patients With Overactive Bladder (Detrusor Overactivity).
Phase of Trial: Phase II
Latest Information Update: 02 Jul 2014
At a glance
- Drugs Vardenafil (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- Sponsors Bayer
- 31 Aug 2018 Biomarkers information updated
- 13 Feb 2013 New source identified and integrated (German Clinical Trials Register: DRKS00004129).
- 09 Feb 2010 Additional trial locations (Canada, Switzerland) identified as reported by ClinicalTrials.gov.